Skip to main content

Table 2 Univariate and multivariate analysis to investigate the risk factor of retained products of conception in pregnant women with placenta previa

From: Clinical significance of retained products of conception in placenta previa: a retrospective analysis

 

Univariate analysis

Multivariate analysisd

Odds ratio (95% Confidence interval)

p-value

Odds ratio (95% Confidence interval)

p-value

Maternal age

  > 35 years vs < 35 years

1.68

(0.73–3.92)

0.22

   

Gestational age at delivery

  > 37 weeks vs < 37 weeks

1.27

(0.55–2.95)

0.58

   

Parity

 Primipara vs Multipara

0.57

(0.24–1.33)

0.19

   

In vitro fertilization pregnancy

 Yes vs. No

1.84

(0.65–5.20)

0.25

   

Tocolytic agent use

 Yes vs. No

2.08

(0.90–4.84)

0.09

   

Warning bleedinga

 Yes vs. No

2.21

(0.96–5.13)

0.06

   

Prior cesarean section

 Yes vs. No

7.13

(2.96–17.19)

 < 0.01

10.70

(3.47–33.00)

 < 0.01

The mode of cesarean section

 Emergency vs Elective

1.21

(0.46–3.18)

0.69

   

The classification of placenta previa

 Major previab vs Minor previac

3.86

(1.49–9.99)

 < 0.01

1.72

(0.55–5.42)

0.35

Main location of placenta

 Anterior wall vs Posterior wall

2.72

(1.01–7.32)

0.048

1.38

(0.37–5.7)

0.63

Placenta accreta spectrum

 Yes vs. No

92.7

(18.39–467.22)

 < 0.01

140.32

(23.84–825.79)

 < 0.01

Prior endometrial curettage

 Yes vs. No

1.37

(0.57–3.33)

0.48

   
  1. aWarning bleeding was defined ass painless genital bleeding from the placenta
  2. bMajor previa was defined as a placenta that covered the internal cervical os
  3. cMinor previa was defined as the leading edge of the placenta, which was located within 2 cm from internal cervical OS but did not cover the cervical os
  4. dMultivariate analysis was adjusted for prior cesarean section, the classification of placenta previa, main location of placenta, and placenta accreta spectrum